Pharma Focus Asia

Aarvik Therapeutics Announces a Global Novel Payload Agreement with NJ Bio, Inc.

Thursday, December 08, 2022

Aarvik Therapeutics announces a global license and assignment Agreement with NJ Bio, Inc. to secure a class of novel proprietary payloads with a wide range of potencies.

Aarvik has an exclusive license to commercialize the novel proprietary payloads from NJ Bio, as well as any materials or products containing the payloads, and can acquire ownership and all rights upon completion of option payments. As part of the agreement, Aarvik will pay NJ Bio an upfront payment, option payments, as well as future success-based milestone and royalty payments for products utilizing the payloads. NJ Bio will also provide all conjugation services for the payloads. Aarvik will partner with NJ Bio to manufacture materials for preclinical studies and clinical trials.

“We are excited to secure a set of novel payloads for our ADC programs from NJ Bio and to benefit from NJ Bio’s deep chemistry and bioconjugation expertise with ADCs,” said Jagath Reddy Junutula, Ph.D., Co-founder, President, and CEO of Aarvik Therapeutics. “NJ Bio will be an excellent research, development, and manufacturing partner for Aarvik. The payloads from NJ Bio complement the novel therapeutic antibodies from Aarvik.”

“We are thrilled to provide Aarvik with a class of novel payloads for their next-generation ADC program. The ADC development experience and innovative antibodies from Aarvik combined with our bioconjugation and novel linker-payload synthesis expertise can be synergistic. We look forward to a very exciting time with Aarvik to revolutionize ADC therapies for patients with cancer,” said Nareshkumar Jain, President, and CEO of NJ Bio.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024